Barry Cheskin | President & CEO (Co-Founder & Director)
Mr. Cheskin is a seasoned medical device executive who began his career in the medical device industry in 1983 as a senior engineer at C.R. Bard. Prior to founding PowerVision, he was President & CEO of a nanotechnology-based medical device company, NanoGram Devices Corp., which he sold to its largest competitor just nine months after arriving there. Prior to that, he was the President & CEO of minimally invasive cancer device company RITA Medical Systems, Inc. which he grew to approximately $18MM in sales after taking it public in 2000. Prior to that, he was a Division President at another medical device company, Datascope Corp., where he launched the VasoSeal vascular puncture sealing product and brought his division to profitability. While at Datascope, he also sold its Angioplasty Division to Boston Scientific. Mr. Cheskin served as a Senior Associate in the management consulting firm of Booz, Allen & Hamilton. Mr. Cheskin also serves on the Boards of early stage medical device companies. He holds a B.S. degree in Mechanical Engineering from MIT, an M.S. degree in Mechanical Engineering from Stanford University and an MBA from Columbia Business School.
George Green, PhD | Vice President, Materials and Technology
Dr. Green has over 25 years of experience in medical device R&D, primarily in ophthalmology. Most recently, he was Vice President, R&D for Bausch & Lomb, Inc. Prior to that, he served in various senior positions at Bausch & Lomb, Alcon and other companies. Dr. Green holds a Bachelor of Arts degree in Chemistry from the University of California at Santa Barbara and a Doctorate degree in Chemistry from the University of Liverpool in England.
S. Arieh Zak, Esq. | Senior VP, Regulatory/Quality/Clinical & General Counsel
Mr. Zak has 20 years of experience in medical devices. Most recently, he was Associate General Counsel at Covance, Inc. Prior to that, he held a variety of positions at Datascope Corp. including Corporate Counsel, General Manager, Genisphere Inc. (a Datascope subsidiary) and Vice President, Regulatory Affairs. Mr. Zak holds a Bachelor of Arts degree in Mathematics from Yeshiva University and a J.D. from Columbia Law School.
Terry Smiley | Vice President, Research & Development
Mr. Smiley has worked in the medical device industry for 15 years and has been the chief designer of PowerVision’s current product since joining the effort, at its inception, 10 years ago. Prior to joining PowerVision, Mr. Smiley worked for several Bay Area design consultancies designing and manufacturing early stage medical devices and biotech instruments, including the Converge Anastomosis delivery system, the Accuray Cyberknife, the EMD Millipore easyCyte, and the ForteBio Octet systems. Mr. Smiley holds a B.S. in Mechanical Engineering from Cal Poly, San Luis Obispo.
David Sanderson | Senior Director, Manufacturing and Program Management
Mr. Sanderson has worked at PowerVision since 2012. He has 18 years of experience in the medical device industry with responsibilities ranging from Research and Development, Operations, Program/Project Management and Process Development Engineering. Prior to PowerVision, he was Director of Research and Development at BioCardia, Inc. and an Engineering Manager at Xtent, Inc. Mr. Sanderson has an MBA degree from Santa Clara University and a Master’s Degree in Mechanical Engineering from Brigham Young University.
Bettina Kohler | Senior Director, Clinical Marketing and Professional Education
Ms. Bettina Kohler is an experienced marketing professional, focused on eye care in the medical device industry. Ms. Kohler was a Marketing Manager for contact lenses at CooperVision, Inc. and, prior to that, served in various global and regional Product Management and Brand Marketing roles at Carl Zeiss Vision and Carl Zeiss Meditec, Inc. Ms. Kohler holds a Diploma Engineer degree in Ophthalmic Optics from the University of Applied Sciences in Aalen, Germany and an MBA degree from the University of San Francisco.
Board of Directors
Advanced Technology Ventures
Frazier Healthcare Ventures
J&J Development Corp
David Chang, M.D.
Internationally acclaimed cataract surgeon; former President, ASCRS and the Chief Medical Editor of EyeWorld; maintains a private practice in Los Altos, California.
Ralph Chu, M.D.
An expert in cataract and refractive surgery; he has participated in numerous FDA studies, is on the editorial board of several leading journals and is currently Medical Director, Chu Vision Institute.
Adrian Glasser, Ph.D.
An independent consultant with expertise in the physiological optics of accommodation and presbyopia and the measurement of accommodation; Adrian Glasser Consulting Services, LLC.
Terry Kim, M.D.
A leading specialist in cataract surgery, corneal transplantation, and refractive surgery; serves as Associate Director, Corneal/External Disease and Refractive Surgery Services at Duke Eye Center.
Doug Koch, M.D.
An internationally recognized expert in anterior segment surgery, Dr. Koch is the Allen, Mosbacher, and Law Chair of Ophthalmology, and Professor of Ophthalmology at Baylor College of Medicine. He is also the recipient of several prestigious honors, including the American Academy of Ophthalmology Lifetime Achievement award.
Sam Masket, M.D.
An expert eye surgeon; former President, ASCRS and has authored numerous articles and two textbooks on ophthalmology; maintains an active private practice in Los Angeles, California.
Louis (Skip) Nichamin, M.D.
An authority on IOL’s and cataract and refractive surgery; served as the Chairman of the Cataract Clinical Committee, American Society of Cataract and Refractive Surgery (ASCRS).
Chirag Patel, M.D.
An accomplished specialist in cataract, cornea and refractive surgery, Dr. Patel serves as the Medical Director of the Turner Eye Institute in the San Francisco Bay Area. He is also actively participating in innovative clinical research.
Liliana Werner, M.D., Ph.D.
A prominent ophthalmic researcher; currently Associate Professor, Ophthalmology at the Moran Eye Center at the University of Utah.
PowerVision, Inc. is a private company focused on developing a novel accommodating intraocular lens, which is designed to restore True AccommodationTM. Our innovative FluidVision® accommodating intraocular lens (IOL) is poised to help individuals affected by presbyopia and/or cataracts regain the ability to dynamically adjust focus for clear vision at all distances.
50 years ago, vision correction surgery was changed forever by the invention of the intraocular lens, which is used to treat a cataract – a clouding and hardening of the dime sized, normally clear, crystalline lens inside your eye which can rob you of your vision in your 60’s, 70’s and 80’s.
PowerVision set out to dramatically improve vision correction surgery again. We began the development of our FluidVision IOL, which mimics the way a healthy eye works and can restore clear vision at all distances, near, far and everywhere in between. It uses a tiny amount of fluid inside the lens and natural eye muscles to change shape and adjust focus just the way your healthy eye does.
For the more than 20 million people with cataracts in the U.S. and, ultimately, the more than 90 million with Presbyopia – the loss of ability to focus up close that affects people in their 40’s and 50’s – the FluidVision lens can potentially give them freedom from ever needing glasses, contacts or any vision correction procedure again.
NOTE: The FluidVision® lens is an investigational device and it is not available for sale or use in the United States.